by Md. Rabiul Auwul Mastitis in dairy cattle is a serious issue that affects not just the animals but also has broad social, cultural, economic, and human consequences.
It does in a wide variety of ways and the most remarkable of which are reduced milk yield and produce poor milk quality. This study takes an approach of bioinformatics to track down new targets and biomarkers which can be used to diagnose the clinical and subclinical forms of mastitis and at the same time find the way to treat and manage the disease.
Comparing genes that express at a different level and the protein network, we identified three key genes (CDKN1A, FKBP5 and SLC7A5) and pathways that mastitis includes both in clinical and subclinical form. In functional term, multicellular organismal process regulation, cell population proliferation, protein binding are identified as critical biological processes.
Additionally, machine learning algorithms applied to validate the identified candidate biomarkers. Potential repurposing drug targets are identified based on the commonly selected differentially expressed genes.
PLOS ONE (Medicine) published a clinical update in Research Highlights on 13 May 2026.
The item focuses on Bioinformatics approach to identify potential biomarker and drug target for the clinical and subclinical mastitis disease in dairy cattle.
Review the original article for the full source wording and details.